-
1
المؤلفون: Klaas G. van der Hem, Kaz Groen, Niels W.C.J. van de Donk, Amanda C. Dijk, Nicole C. H. P. van der Burg-de Graauw, Mark-David Levin, Kazem Nasserinejad, Henriette Levenga, Paula F. Ypma, Aart Beeker, L. Strobbe, Inger S. Nijhof, Harm Sinnige, Claudia A.M. Stege, Saskia K. Klein, Roel J. W. van Kampen, Gerjo A. Velders, Ad Koster, Mels Hoogendoorn, Rineke B. L. Leys, Matthijs Westerman, Gert-Jan Timmers, Pieter Sonneveld, Marjan A. Davidis-van Schoonhoven, Sonja Zweegman, Nazik Durdu-Rayman, Matthijs H Silbermann, Ellen van der Spek, Yavuz M. Bilgin
المساهمون: Internal medicine, Hematology, CCA - Cancer Treatment and quality of life
المصدر: Leukemia, 35(9), 2715-2719. Nature Publishing Group
Stege, C A M, Nasserinejad, K, Klein, S K, Timmers, G J, Hoogendoorn, M, Ypma, P F, Nijhof, I S, Velders, G A, Strobbe, L, Durdu-Rayman, N, Westerman, M, Davidis-van Schoonhoven, M A, van Kampen, R J W, Beeker, A, Koster, A, Dijk, A C, van de Donk, N W C J, van der Spek, E, Leys, R B L, Silbermann, M H, Groen, K, van der Burg-de Graauw, N C H P, Sinnige, H A M, van der Hem, K G, Levenga, H, Bilgin, Y M, Sonneveld, P, Levin, M D & Zweegman, S 2021, ' Improving the identification of frail elderly newly diagnosed multiple myeloma patients ', Leukemia, vol. 35, no. 9, pp. 2715-2719 . https://doi.org/10.1038/s41375-021-01162-zمصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Multiple Myeloma/drug therapy, MEDLINE, Newly diagnosed, SDG 3 - Good Health and Well-being, Geriatric Assessment/methods, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, 80 and over, medicine, Humans, Frail elderly, Prospective Studies, Geriatric Assessment, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Hematology, Prognosis, medicine.disease, Survival Rate, Oncology, Identification (biology), Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Multiple Myeloma, business, Follow-Up Studies
وصف الملف: application/pdf
-
2
المؤلفون: Coreline N. Burggraaff, Gregor Verhoef, Otto S. Hoekstra, Marie José Kersten, Lidwine W. Tick, Mels Hoogendoorn, Margreet Oosterveld, Daphne de Jong, Nicole C. H. P. van der Burg-de Graauw, Marinus van Marwijk Kooy, Matthijs H Silbermann, Aart Beeker, Marjolein van der Poel, Bart de Keizer, Eva de Jongh, Jeanette K. Doorduijn, Harry R. Koene, Thomas Stauffer Larsen, Memis Y Bilgin, Lara H Böhmer, Joost W. J. van Esser, Peter de Nully Brown, Marcel Nijland, Maria B.L. Leijs, J.F.M. Pruijt, Anne I.J. Arens, Josée M Zijlstra-Baalbergen, Pieternella J. Lugtenburg, Kon-Siong G. Jie, Rolf E. Brouwer, King H. Lam, Rob Fijnheer, Bronno van der Holt, Francesco d'Amore
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Hematology, Health Technology Assessment (HTA), Pathology, Radiology & Nuclear Medicine, Radiotherapy, CCA - Cancer Treatment and Quality of Life, Clinical Haematology, Stem Cell Aging Leukemia and Lymphoma (SALL), Internal medicine, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and quality of life, Radiology and nuclear medicine
المصدر: Journal of Clinical Oncology, 38(29), 3377-3387. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(29). American Society of Clinical Oncology
Lugtenburg, P J, De Nully Brown, P, Van der Holt, B, D'Amore, F A, Koene, H R, De Jongh, E, Fijnheer, R, Van Esser, J W, Bohmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, Van der Burg-De Graauw, N C, Oosterveld, M, Jie, K S G, Larsen, T S, Van der Poel, M W, Leijs, M B, Silbermann, M H, Van Marwijk Kooy, M, Beeker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, De Keizer, B, Arens, A I, De Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma : A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) ', Journal of Clinical Oncology, vol. 38, no. 29, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418
Journal of clinical oncology, 38(29), 3377-3387. American Society of Clinical Oncology
Lugtenburg, P J, De Nully Brown, P, Van der Holt, B, D'Amore, F A, Koene, H R, De Jongh, E, Fijnheer, R, Van Esser, J W, Bohmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, Van der Burg-De Graauw, N C, Oosterveld, M, Jie, K S G, Larsen, T S, Van der Poel, M W, Leijs, M B, Silbermann, M H, Van Marwijk Kooy, M, Beeker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, De Keizer, B, Arens, A I, De Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-chop with early rituximab intensification for diffuse large b-cell lymphoma : A randomized phase iii trial of the hovon and the nordic lymphoma group (hovon-84) ', Journal of Clinical Oncology, vol. 38, no. 29, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418
Journal of Clinical Oncology, 38, 29, pp. 3377-3387
Journal of Clinical Oncology, 38(29), 3377-3387. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 38(29):38, 3377-3387. American Society of Clinical Oncology
Journal of Clinical Oncology, 38, 3377-3387
Lugtenburg, P J, de Nully Brown, P, van der Holt, B, D'Amore, F A, Koene, H R, de Jongh, E, Fijnheer, R, van Esser, J W, Böhmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, van der Burg-de Graauw, N C, Oosterveld, M, Jie, K-S G, Larsen, T S, van der Poel, M W, Leijs, M B, Silbermann, M H, van Marwijk Kooy, M, Beker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, de Keizer, B, Arens, A I, de Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) ', Journal of Clinical Oncology, vol. 38, no. 29, 38, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418, https://doi.org/DOI: 10.1200/JCO.19.03418مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, CHOP, 0302 clinical medicine, Prednisone, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, response assessment, DOSE-DENSE RITUXIMAB, Induction Chemotherapy, Middle Aged, CHEMOTHERAPY, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Rituximab, Lymphoma, Large B-Cell, Diffuse, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, Adult, medicine.medical_specialty, Vincristine, DOXORUBICIN, Adolescent, Cyclophosphamide, plus cyclophosphamide, elderly-patients, vincristine, Maintenance Chemotherapy, Young Adult, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, Humans, non-hodgkin-lymphoma, OPTIMIZATION, Aged, Chemotherapy, business.industry, medicine.disease, Lymphoma, 030104 developmental biology, exposure, business, Diffuse large B-cell lymphoma, Follow-Up Studies
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7540ecb6cafd809a54c75ab38ea46d
https://cris.maastrichtuniversity.nl/en/publications/14069863-94fd-45a6-a6a0-7e5cfcc2608a -
3دورية أكاديمية
المؤلفون: Jaap J. Zwaginga, Bronno van der Holt, Peter A. te Boekhorst, Bart J. Biemond, Mark-David Levin, René van der Griend, Anneke Brand, Sonja Zweegman, Hans F.M. Pruijt, Vera M.J. Novotny, Art Vreugdenhil, Marco R. de Groot, Okke de Weerdt, Elisabeth C.M. van Pampus, Tanja M. van Maanen-Lamme, Shulamiet Wittebol, Martin R. Schipperus, Matthijs H. Silbermann, Peter C. Huijgens, Marleen Luten, Rene Hollestein, Jan A.C. Brakenhoff, Jolanda G. Schrama, Fransje A.A. Valster, Gerjo A. Velders, Harry R. Koene
المصدر: Haematologica, Vol 100, Iss 3 (2015)
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
4
المؤلفون: Inge Ludwig, Ellen van der Spek, Paul A F Geerts, Pieter Sonneveld, Margriet Oosterveld, Yavuz M. Bilgin, Savita Soechit, Niels W.C.J. van de Donk, Noortje Thielen, Nicole C H P de Graauw, Mark-David Levin, Gert Jan Timmers, Inger S. Nijhof, Kazem Nasserinejad, Alain Kentos, Marjolein van der Klift, Claudia A.M. Stege, Saskia K. Klein, Esther G.M. De Waal, Matthijs H Silbermann, Maaike Sohne, Marie-Christiane Vekemans, Sonja Zweegman, Roel J.W. van Kampen, Nazik Durdu-Rayman
المساهمون: UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'hématologie, Internal medicine, Hematology, CCA - Cancer Treatment and quality of life
المصدر: Journal of clinical oncology, Vol. 39, no. 25, p. 2758-2767 (2021)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143مصطلحات موضوعية: Oncology, Boron Compounds, Male, Cancer Research, medicine.medical_specialty, Frail Elderly, Glycine, Dexamethasone, Ixazomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Prospective Studies, Prospective cohort study, Survival rate, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Daratumumab, Antibodies, Monoclonal, medicine.disease, Prognosis, Discontinuation, Clinical trial, Survival Rate, chemistry, 030220 oncology & carcinogenesis, Quality of Life, Female, business, Multiple Myeloma, 030215 immunology, medicine.drug, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd16999f1d8f8fc2bbefd1520cedee3
https://hdl.handle.net/2078.1/261917 -
5
المصدر: European Journal of Cancer and Clinical Oncology. 26:321-325
مصطلحات موضوعية: Drug, Pathology, medicine.medical_specialty, B16 Malignant Melanoma, Combination therapy, Ratón, Colorectal cancer, media_common.quotation_subject, medicine.medical_treatment, Melanoma, Experimental, Mice, Inbred Strains, Mice, Breast cancer, Antineoplastic Combined Chemotherapy Protocols, medicine, Animals, Ifosfamide, media_common, Chemotherapy, business.industry, Mammary Neoplasms, Experimental, Drug Synergism, medicine.disease, Nimustine, Oncology, Colonic Neoplasms, Cancer research, business, medicine.drug